These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia. Addington D; Addington J Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754 [TBL] [Abstract][Full Text] [Related]
3. The dexamethasone suppression test in residual schizophrenia with depression. Munro JG; Hardiker TM; Leonard DP Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488 [TBL] [Abstract][Full Text] [Related]
4. Depression, negative and positive symptoms, and the DST in schizophrenia. Minas IH; Jackson HJ; Joshua SD; Burgess PM Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337 [TBL] [Abstract][Full Text] [Related]
5. Negative symptoms of schizophrenia and the dexamethasone suppression test. Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850 [TBL] [Abstract][Full Text] [Related]
6. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test. Tandon R; Silk KR; Greden JF; Goodson J; Hariharan M; Meador-Woodruff JH; Kronfol Z Biol Psychiatry; 1989 Mar; 25(6):788-92. PubMed ID: 2629711 [No Abstract] [Full Text] [Related]
11. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. Muscettola G; Barbato G; de Bartolomeis A; Monteleone P; Pickar D Psychiatry Res; 1990 Sep; 33(3):259-67. PubMed ID: 2243901 [TBL] [Abstract][Full Text] [Related]
12. Negative and depressive symptoms in suicidal schizophrenics. Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667 [TBL] [Abstract][Full Text] [Related]
13. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients. Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731 [TBL] [Abstract][Full Text] [Related]
14. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605 [TBL] [Abstract][Full Text] [Related]
15. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients. Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952 [TBL] [Abstract][Full Text] [Related]
16. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients. Johnson GF; Hunt G; Kerr K; Caterson I Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587 [TBL] [Abstract][Full Text] [Related]
17. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect. Rybakowski J; Plocka M J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients. Perényi A; Frecska E; Rihmer Z; Arató M Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661 [TBL] [Abstract][Full Text] [Related]
19. Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables. Mauri MC; Vita A; Giobbio GM; Ferrara A; Dieci M; Bitetto A; Altamura AC Int Clin Psychopharmacol; 1994; 9(1):3-7. PubMed ID: 8195579 [TBL] [Abstract][Full Text] [Related]
20. Dexamethasone suppression test in recently detoxified alcoholics: clinical implications. Khan A; Ciraulo DA; Nelson WH; Becker JT; Nies A; Jaffe JH J Clin Psychopharmacol; 1984 Apr; 4(2):94-7. PubMed ID: 6707246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]